Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim;

Mineralcorticoid receptor blockers in chronic kidney disease Sara Erraez; Manuel López-Mesa; Pablo Gómez-Fernández;

Some thoughts about the ¿Consensus statement on smoking and vascular risk¿ from the Spanish Autonomous Societies of Hypertension and Vascular Risk Javier Nieto Iglesias; Alfonso Pobes Martínez de Salinas; Nicolás Roberto Robles Pérez-Monteoliva;